Works matching DE "CARBIDOPA"

Results: 233

Detecting placebo and drug effects on Parkinson's disease symptoms by longitudinal item‐score models.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2021, v. 10, n. 4, p. 309, doi. 10.1002/psp4.12601

By:

Chen, Chao;
Jönsson, Siv;
Yang, Shuying;
Plan, Elodie L.;
Karlsson, Mats O.

Publication type:

Article

Target-Controlled Sedation with Propofol Infusion for PEG-J Placement in Advanced Parkinson's Disease: A Prospective Observational Study on Safety and Feasibility.

Published in:

Life (2075-1729), 2025, v. 15, n. 3, p. 492, doi. 10.3390/life15030492

By:

Szederjesi, Janos;
Săplăcan, Irina;
Lazăr, Alexandra;
Keresztes, Matild;
Muller-Șerban, Georgiana-Mihaela;
Szasz, Jozsef Attila;
Grigorescu, Bianca Liana

Publication type:

Article

Case report: Treatment of parkinsonism secondary to ciltacabtagene autoleucel using a combination dopaminergic regimen.

Published in:

Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1444010

By:

Aliakbar, Raya;
Manouvakhova, Olga;
Wong, Cindy;
Htut, Myo;
Pulst-Korenberg, Johannes;
Janakiram, Murali;
Rosenzweig, Michael;
Goldsmith, Scott R.;
Mason, Xenos L.

Publication type:

Article

Case report: Treatment of parkinsonism secondary to ciltacabtagene autoleucel using a combination dopaminergic regimen.

Published in:

Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1444010

By:

Aliakbar, Raya;
Manouvakhova, Olga;
Wong, Cindy;
Htut, Myo;
Pulst-Korenberg, Johannes;
Janakiram, Murali;
Rosenzweig, Michael;
Goldsmith, Scott R.;
Mason, Xenos L.

Publication type:

Article

The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development program.

Published in:

Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.1036068

By:

LeWitt, Peter A.;
Stocchi, Fabrizio;
Arkadir, David;
Caraco, Yoseph;
Adar, Liat;
Perlstein, Itay;
Case, Ryan;
Giladi, Nir

Publication type:

Article

Transcranial Direct Current Stimulation on Parkinson's Disease: Systematic Review and Meta-Analysis.

Published in:

Frontiers in Neurology, 2022, v. 12, p. 1, doi. 10.3389/fneur.2021.794784

By:

Oliveira, Paloma Cristina Alves de;
Araújo, Thiago Anderson Brito de;
Machado, Daniel Gomes da Silva;
Rodrigues, Abner Cardoso;
Bikson, Marom;
Andrade, Suellen Marinho;
Okano, Alexandre Hideki;
Simplicio, Hougelle;
Pegado, Rodrigo;
Morya, Edgard

Publication type:

Article

Parkinson's disease: carbidopa, nausea, and dyskinesia.

Published in:

Clinical Pharmacology, 2014, v. 6, p. 189, doi. 10.2147/CPAA.S72234

By:

Hinz, Marty;
Stein, Alvin;
Cole, Ted

Publication type:

Article

The Parkinson's disease death rate: carbidopa and vitamin B6.

Published in:

Clinical Pharmacology, 2014, v. 6, p. 161, doi. 10.2147/CPAA.S70707

By:

Hinz, Marty;
Stein, Alvin;
Cole, Ted

Publication type:

Article

Percutaneous Endoscopic Gastrostomy with Jejunal Extension Tube for the Delivery of Levodopa Carbidopa Intestinal Gel: Clinical Practice Guidelines of the Romanian Society of Digestive Endoscopy.

Published in:

Journal of Gastrointestinal & Liver Diseases, 2019, v. 28, n. 3, p. 349, doi. 10.15403/jgld-404

By:

Gheorghe, Cristian;
Dumitru, Eugen;
Ciocîrlan, Mihai;
Dobru, Daniela;
Drug, Vasile;
Goldiș, Adrian;
Jinga, Mariana;
Manuc, Mircea;
Săftoiu, Adrian;
Seicean, Andrada;
Cotruța, Bogdan;
Bancilă, Ion;
Pițigoi, Dan;
Mercea, Voicu Alexandru;
Tanțău, Marcel

Publication type:

Article

What drugs modify the risk of iatrogenic impulse-control disorders in Parkinson's disease? A preliminary pharmacoepidemiologic study.

Published in:

PLoS ONE, 2020, v. 15, n. 1, p. 1, doi. 10.1371/journal.pone.0227128

By:

Jeon, Nakyung;
Bortolato, Marco

Publication type:

Article

Effect of Repeated Intravenous Amantadine Infusions in Patients with Parkinson's Disease: An Open‐Label Pilot Study.

Published in:

CTS: Clinical & Translational Science, 2019, v. 12, n. 6, p. 586, doi. 10.1111/cts.12684

By:

Khlebtovsky, Alexander;
Steiner, Israel;
Treves, Therese;
Djaldetti, Ruth

Publication type:

Article

Linezolid and Rasagiline -- A culprit for serotonin syndrome.

Published in:

2016

By:

Hisham, Mohamed;
Sivakumar, Mundalipalayam N.;
Nandakumar, V.;
Lakshmikanthcharan, S.

Publication type:

Case Study

Development and Validation of a New LC-MS/MS Bioanalytical Method for the Simultaneous Determination of Levodopa, Levodopa Methyl Ester, and Carbidopa in Human Plasma Samples.

Published in:

Molecules, 2023, v. 28, n. 11, p. 4264, doi. 10.3390/molecules28114264

By:

Molteni, Linda;
Charlier, Bruno;
Izzo, Viviana;
Coglianese, Albino;
Conti, Valeria;
Eleopra, Roberto;
Cilia, Roberto;
Capelli, Chiara;
D'Urso, Annachiara;
de Grazia, Ugo

Publication type:

Article

Dopamine is an aryl hydrocarbon receptor agonist.

Published in:

Biochemical Journal, 2020, v. 477, n. 19, p. 3899, doi. 10.1042/BCJ20200440

By:

Hyejin Park;
Un-ho Jin;
Karki, Keshav;
Jayaraman, Arul;
Allred, Clint;
Michelhaugh, Sharon K.;
Mittal, Sandeep;
Chapkin, Robert S.;
Safe, Stephen

Publication type:

Article

Greenness and whiteness appraisal for bioanalysis of quetiapine, levodopa and carbidopa in spiked human plasma by high performance thin layer chromatography.

Published in:

BMC Chemistry, 2024, v. 18, n. 1, p. 1, doi. 10.1186/s13065-024-01309-w

By:

Hindam, Finan T.;
Abou Al Alamein, Amal M.;
Arafa, Reham M.;
Ahmed, Neven;
Eltanany, Basma M.

Publication type:

Article

Effect of zonisamide on post-traumatic Holmes' tremor.

Published in:

Neurology & Clinical Neuroscience, 2016, v. 4, n. 5, p. 184, doi. 10.1111/ncn3.12063

By:

Sekimoto, Satoko;
Oyama, Genko;
Izawa, Nana;
Ueno, Sinichi;
Jo, Takayuki;
Shimo, Yasushi;
Nakajima, Asuka;
Nakajima, Madoka;
Umemura, Atsushi;
Arai, Hajime;
Hattori, Nobutaka

Publication type:

Article

Reply to: Partially Levodopa‐Responsive Parkinsonism in a Carrier of a Novel Pathogenic CLTC Variant.

Published in:

Movement Disorders Clinical Practice, 2024, v. 11, n. 6, p. 751, doi. 10.1002/mdc3.14039

By:

Nardecchia, Francesca;
Martinelli, Simone;
Pollini, Luca;
Leuzzi, Vincenzo

Publication type:

Article

Subthalamic Nucleus Deep Brain Stimulation as Rescue Therapy for Levodopa Carbidopa Intestinal Gel–Associated Biphasic‐Like Dyskinesias.

Published in:

Movement Disorders Clinical Practice, 2021, v. 8, n. 7, p. 1155, doi. 10.1002/mdc3.13277

By:

Marano, Massimo;
Fasano, Alfonso

Publication type:

Article

Reply to Comment on: Successful Treatment of Levodopa/Carbidopa Intestinal Gel Associated "Biphasic‐Like" Dyskinesia with Pallidal Deep Brain Stimulation.

Published in:

Movement Disorders Clinical Practice, 2021, v. 8, n. 5, p. 814, doi. 10.1002/mdc3.13221

By:

Mulroy, Eoin;
Leta, Valentina;
Zrinzo, Ludvic;
Foltynie, Thomas;
Chaudhuri, Kallol Ray;
Limousin, Patricia

Publication type:

Article

Successful Treatment of Levodopa/Carbidopa Intestinal Gel Associated "Biphasic‐like" Dyskinesia with Pallidal Deep Brain Stimulation.

Published in:

Movement Disorders Clinical Practice, 2021, v. 8, n. 2, p. 273, doi. 10.1002/mdc3.13132

By:

Mulroy, Eoin;
Leta, Valentina;
Zrinzo, Ludvic;
Foltynie, Thomas;
Chaudhuri, K. Ray;
Limousin, Patricia

Publication type:

Article

Levodopa/Carbidopa Intestinal Gel Long‐Term Outcome in Parkinson's Disease: Focus on Dyskinesia.

Published in:

Movement Disorders Clinical Practice, 2020, v. 7, n. 8, p. 930, doi. 10.1002/mdc3.13068

By:

Fabbri, Margherita;
Zibetti, Maurizio;
Calandra‐Buonaura, Giovanna;
Contin, Manuela;
Sambati, Luisa;
Mohamed, Susan;
Romagnolo, Alberto;
Berchialla, Paola;
Imbalzano, Gabriele;
Giannini, Giulia;
Rizzone, Mario G.;
Artusi, Carlo Alberto;
Cortelli, Pietro;
Lopiano, Leonardo

Publication type:

Article

Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and Safinamide.

Published in:

Movement Disorders Clinical Practice, 2020, v. 7, n. 3, p. 343, doi. 10.1002/mdc3.12921

By:

Schade, Sebastian;
Mollenhauer, Brit;
Trenkwalder, Claudia

Publication type:

Article

The Gut Microbiome: A Therapeutically Targetable Site of Peripheral Levodopa Metabolism.

Published in:

Movement Disorders Clinical Practice, 2019, v. 6, n. 7, p. 547, doi. 10.1002/mdc3.12828

By:

Mulroy, Eoin;
Bhatia, Kailash P.

Publication type:

Article

How Do I Manage Patients With the Levodopa/Carbidopa Intestinal Gel?

Published in:

Movement Disorders Clinical Practice, 2019, v. 6, n. 2, p. 181, doi. 10.1002/mdc3.12701

By:

Vijiaratnam, Nirosen;
Sue, Carolyn M.

Publication type:

Article

Levodopa/Carbidopa Intestinal Gel Infusion Therapy: Focus on Gait and Balance.

Published in:

Movement Disorders Clinical Practice, 2018, v. 5, n. 5, p. 542, doi. 10.1002/mdc3.12640

By:

Rispoli, Vittorio;
Golfrè Andreasi, Nico;
Penna, Giovanna;
Contini, Eleonora;
Sensi, Mariachiara;
Preda, Francesca

Publication type:

Article

Implementing Levodopa‐Carbidopa Intestinal Gel for Parkinson Disease: Insights from US Practitioners.

Published in:

Movement Disorders Clinical Practice, 2018, v. 5, n. 4, p. 383, doi. 10.1002/mdc3.12630

By:

Burack, Michelle;
Aldred, Jason;
Zadikoff, Cindy;
Vanagunas, Arvydas;
Klos, Kevin;
Bilir, Bahri;
Fernandez, Hubert H.;
Standaert, David G.

Publication type:

Article

Levodopa-Carbidopa Intestinal Gel in a Pediatric Parkinsonism-plus Syndrome.

Published in:

Movement Disorders Clinical Practice, 2017, v. 4, n. 5, p. 791, doi. 10.1002/mdc3.12509

By:

Vita, Maria Gabriella;
Bove, Francesco;
Mariotti, Paolo;
Riccioni, Maria Elena;
Leuzzi, Vincenzo;
Bentivoglio, Anna Rita

Publication type:

Article

Cathecol-O-methyltransferase inhibitors: another possibly useful pharmacological tool for treating Parkinson's disease in pregnancy?

Published in:

2017

By:

Basile, Stefano;
Pinelli, Sara;
Garibaldi, Silvia;
Altamura, Claudia;
Calcagno, Marco;
Salerno, Maria Giovanna

Publication type:

journal article

Carbidopa: beyond Parkinson's disease.

Published in:

Clinical Autonomic Research, 2025, v. 35, n. 3, p. 347, doi. 10.1007/s10286-025-01122-y

By:

Lenka, Abhishek;
Vernino, Steven

Publication type:

Article

Effects of levodopa/carbidopa intestinal gel infusion on autonomic symptoms in advanced Parkinson's disease: a systematic review.

Published in:

Clinical Autonomic Research, 2025, v. 35, n. 2, p. 159, doi. 10.1007/s10286-024-01090-9

By:

Galli, Silvia;
De Carolis, Lanfranco;
Bianchini, Edoardo;
Alborghetti, Marika;
Caliò, Bianca;
Pacilio, Pierre;
Fanciulli, Alessandra;
Pontieri, Francesco E.;
Rinaldi, Domiziana

Publication type:

Article

[<sup>18</sup>F]FDOPA positron emission tomography for cardiac innervation imaging: a new way or a dead-end street?

Published in:

Clinical Autonomic Research, 2022, v. 32, n. 6, p. 399, doi. 10.1007/s10286-022-00893-y

By:

Treglia, Giorgio;
Piccardo, Arnoldo;
Garibotto, Valentina

Publication type:

Article

Substantial renal conversion of L-threo-3,4-dihydroxyphenylserine (droxidopa) to norepinephrine in patients with neurogenic orthostatic hypotension.

Published in:

Clinical Autonomic Research, 2019, v. 29, n. 1, p. 113, doi. 10.1007/s10286-018-0564-5

By:

Lamotte, Guillaume;
Holmes, Courtney;
Sullivan, Patti;
Goldstein, David S.

Publication type:

Article

Differential diagnosis of suspected neurogenic orthostatic hypotension in a patient with Parkinson disease.

Published in:

2017

By:

Lew, Mark;
Kremens, Daniel

Publication type:

Letter

Initiating droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease.

Published in:

2017

By:

Claassen, Daniel;
Lew, Mark

Publication type:

Letter

Managing neurogenic orthostatic hypotension with droxidopa in a patient with Parkinson disease, atrial fibrillation, and hypertension.

Published in:

2017

By:

Mehdirad, Ali;
Karabin, Beverly;
Gupta, Fiona

Publication type:

Letter

Polypharmacy: droxidopa to treat neurogenic orthostatic hypotension in a patient with Parkinson disease and type 2 diabetes mellitus.

Published in:

2017

By:

Vernino, Steven;
Claassen, Daniel

Publication type:

Letter

Subcutaneous Levodopa: A New Engine for the Vintage Molecule.

Published in:

Neurology & Therapy, 2024, v. 13, n. 4, p. 1055, doi. 10.1007/s40120-024-00635-4

By:

Poplawska-Domaszewicz, Karolina;
Batzu, Lucia;
Falup-Pecurariu, Cristian;
Chaudhuri, K. Ray

Publication type:

Article

The Catechol O-Methyltransferase Inhibitor Entacapone in the Treatment of Parkinson's Disease: Personal Reflections on a First-in-Class Drug Development Programme 40 Years On.

Published in:

Neurology & Therapy, 2024, v. 13, n. 4, p. 1039, doi. 10.1007/s40120-024-00629-2

By:

Männistö, Pekka T.;
Keränen, Tapani;
Reinikainen, Kari J.;
Hanttu, Anna;
Pollesello, Piero

Publication type:

Article

Comparative Effectiveness of Carbidopa/Levodopa Enteral Suspension and Deep Brain Stimulation on Pill Burden Reduction in Medicare Fee-for-Service Patients with Advanced Parkinson's Disease.

Published in:

Neurology & Therapy, 2023, v. 12, n. 2, p. 459, doi. 10.1007/s40120-022-00433-w

By:

Soileau, Michael J.;
Pagan, Fernando L.;
Fasano, Alfonso;
Rodriguez-Cruz, Ramon;
Yan, Connie H.;
Gupta, Niodita R.;
Teigland, Christie L.;
Pulungan, Zulkarnain;
Schinkel, Jill K.;
Kandukuri, Prasanna L.;
Ladhani, Omar A.;
Siddiqui, Mustafa S.

Publication type:

Article

Patterns of Daily Motor-Symptom Control with Carbidopa/Levodopa Enteral Suspension Versus Oral Carbidopa/Levodopa Therapy in Advanced Parkinson's Disease: Clinical Trial Post Hoc Analyses.

Published in:

Neurology & Therapy, 2022, v. 11, n. 2, p. 711, doi. 10.1007/s40120-022-00332-0

By:

Pahwa, Rajesh;
Aldred, Jason;
Gupta, Niodita;
Terasawa, Emi;
Garcia-Horton, Viviana;
Steffen, David R.;
Kandukuri, Prasanna L.;
Chaudhari, Vivek S.;
Jalundhwala, Yash J.;
Bao, Yanjun;
Kukreja, Pavnit;
Isaacson, Stuart H.

Publication type:

Article

Reduced Plasma Levodopa Fluctuations with More Frequent Administration of a Novel Carbidopa/Levodopa Functionally Scored Tablet.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 4, p. 380, doi. 10.1002/cpdd.1360

By:

Chase, Thomas N.;
AL‐Sabbagh, Ahmad;
Koga, Minako;
Clarence‐Smith, Kathleen

Publication type:

Article

A metabolomics study in aqueous humor discloses altered arginine metabolism in Parkinson's disease.

Published in:

Fluids & Barriers of the CNS, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12987-023-00494-5

By:

Serrano-Marín, Joan;
Marin, Silvia;
Bernal-Casas, David;
Lillo, Alejandro;
González-Subías, Marc;
Navarro, Gemma;
Cascante, Marta;
Sánchez-Navés, Juan;
Franco, Rafael

Publication type:

Article

The Association of Iron and the Pathologies of Parkinson's Diseases in MPTP/MPP<sup>+</sup>-Induced Neuronal Degeneration in Non-human Primates and in Cell Culture.

Published in:

Frontiers in Aging Neuroscience, 2019, p. N.PAG, doi. 10.3389/fnagi.2019.00215

By:

Shi, Liangqin;
Huang, Chao;
Luo, Qihui;
Rogers, Edmond;
Xia, Yu;
Liu, Wentao;
Ma, Wenjing;
Zeng, Wen;
Gong, Li;
Fang, Jing;
Tang, Li;
Cheng, Anchun;
Shi, Riyi;
Chen, Zhengli

Publication type:

Article

The Parkinson's Disease Death Rate: Carbidopa and Vitamin B6 [Retraction].

Published in:

Clinical Pharmacology, 2021, v. 13, p. 41, doi. 10.2147/CPAA.S308256

By:

Hinz, Marty;
Stein, Alvin;
Cole, Ted

Publication type:

Article

Parkinson's Disease: Carbidopa, Nausea, and Dyskinesia [Retraction].

Published in:

Clinical Pharmacology, 2021, v. 13, p. 43, doi. 10.2147/CPAA.S308259

By:

Hinz, Marty;
Stein, Alvin;
Cole, Ted

Publication type:

Article

The Parkinson's Disease Death Rate: Carbidopa and Vitamin B6 [Expression of Concern].

Published in:

Clinical Pharmacology, 2020, v. 12, p. 43, doi. 10.2147/CPAA.S240231

By:

Hinz, Marty;
Stein, Alvin;
Cole, Ted

Publication type:

Article

Parkinson's Disease: Carbidopa, Nausea, and Dyskinesia [Expression of Concern].

Published in:

Clinical Pharmacology, 2020, v. 12, p. 45, doi. 10.2147/CPAA.S240233

By:

Hinz, Marty;
Stein, Alvin;
Cole, Ted

Publication type:

Article

Von Economo’s disease and postencephalitic parkinsonism responsive to carbidopa and levodopa.

Published in:

2018

By:

Bigman, Daniel Y;
Bobrin, Bradford D

Publication type:

Case Study

Onset and duration of effect of extended-release carbidopa-levodopa in advanced Parkinson's disease.

Published in:

Neuropsychiatric Disease & Treatment, 2018, v. 14, p. 839, doi. 10.2147/NDT.S153321

By:

Hauser, Robert A;
Ellenbogen, Aaron;
Khanna, Sarita;
Gupta, Suneel;
Modi, Nishit B

Publication type:

Article

Parkinson's disease managing reversible neurodegeneration.

Published in:

Neuropsychiatric Disease & Treatment, 2016, v. 12, p. 763, doi. 10.2147/NDT.S98367

By:

Hinz, Marty;
Stein, Alvin;
Cole, Ted;
McDougall, Beth;
Westaway, Mark

Publication type:

Article